Tracked deals
5
5 tracked deals across 2023-2026.
Operating Company
Healthcare
Summit Clinical Research Solutions
San Antonio, Texas, United States
Formerly known as Pinnacle Clinical Research, Pinnacle Clinical Research (LongueVue Capital), Pinnacle Clinical Research (Pinnacle site network)
An integrated clinical research organization formed by bringing Summit Clinical Research and Pinnacle Clinical Research together under one brand. Its platform combines clinical-trial site operations and partner-site networks with recruitment, specialty CRO services, medical communications, and scientific strategy for sponsors across complex therapeutic areas.
- Focus Areas
- Clinical research site network, Clinical trial execution and site management, Patient recruitment
- Website
- summitclinicalresearch.com
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Addon
5 addon
Summit Clinical Research Solutions Acquisition Volume by Year
Last 4 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
September 10, 2026
- Buyer
- Summit Clinical Research Solutions
- Target
- Dallas Research Institute
- Industry
- Healthcare Services
- Location
- Texas, United States
- Type
- Addon
Summit Clinical Research Solutions acquired Dallas Research Institute through its Pinnacle Clinical Research site network. The acquisition adds a clinical research site focused on metabolic and liver diseases and expands Pinnacle’s presence in the Dallas–Fort Worth area; the announcement describes the transaction as completed.
-
- Buyer
- Summit Clinical Research, Pinnacle Clinical Research, LongueVue Capital
- Target
- Houston Research Institute
- Industry
- Healthcare Services
- Location
- Texas, United States
- Type
- Addon
LongueVue Capital portfolio company Summit Clinical Research, in partnership with Pinnacle Clinical Research, completed a strategic investment in Houston Research Institute (HRI) to expand Summit's metabolic/hepatology clinical research capabilities. The transaction brings HRI's scientific expertise into Summit/Pinnacle's site network and is accompanied by leadership additions — Dr. Mazen Noureddin named Co-Chairman (and Chief Scientific Officer), Dr. Naim Alkhouri as Chief Academic Officer, and Brandon Early as President.
-
September 27, 2024
- Buyer
- Pinnacle Clinical Research, LongueVue Capital
- Target
- Jubilee Clinical Research, Inc.
- Industry
- Healthcare Services
- Location
- Nevada, United States
- Type
- Addon
LongueVue Capital-backed Pinnacle Clinical Research has acquired Jubilee Clinical Research, a Las Vegas-based multi-therapeutic clinical trial site focused on metabolic and cardiovascular indications. The add-on expands Pinnacle's West Coast footprint and therapeutic expertise; Jubilee's founder Dr. Elliot Shin will continue to lead the site within the Pinnacle network.
-
June 18, 2024
- Buyer
- Pinnacle Clinical Research, LongueVue Capital
- Target
- Kerwin Medical Center, The Cognitive and Research Center of New Jersey, Bellaire Clinical Research, Palmetto Clinical Research - Low Country, Dallas Research Institute
- Industry
- Healthcare Services
- Location
- United States
- Type
- Addon
LongueVue Capital’s portfolio company Pinnacle Clinical Research has completed investments/acquisitions of five clinical research sites: Kerwin Medical Center, The Cognitive and Research Center of New Jersey, Bellaire Clinical Research, Palmetto Clinical Research – Low Country, and Dallas Research Institute. The additions broaden Pinnacle’s U.S. geographic footprint and expand therapeutic-area expertise, including central nervous system focus for Alzheimer’s disease indications via Kerwin Medical Center and CRCNJ.
-
January 10, 2023
- Buyer
- Pinnacle Clinical Research, LongueVue Capital
- Target
- South Texas Research Institute
- Industry
- Healthcare Services
- Location
- Texas, United States
- Type
- Addon
Pinnacle Clinical Research, a LongueVue Capital portfolio company, has completed a combination with South Texas Research Institute (STRI). The deal expands Pinnacle's clinical site network to six dedicated locations, strengthens recruitment capabilities (notably for NASH/NAFLD trials) and increases geographic reach into the Rio Grande Valley.
Related Acquisition Pages
Selling a company? Get in front of buyers like Summit Clinical Research Solutions
Turn tracked acquisition activity into an outreach-ready buyer list.